S PA: PTEN loss in the continuum of common cancers, rare
S PA: PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 2011, 11:289?01. 17. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, Lieberman J, Rigoutsos I, Pandolfi PP: Codingindependent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147:344?57. 18. Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang HH, Liu X, Liang DS, Lu YJ, Shan HL, Jiang HC: Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell Physiol Biochem 2012, 30:631?41. 19. Fu LL, Wen X, Bao JK, Liu B: MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 2012, 44:733?36. 20. Chalhoub N, Baker SJ: PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009, 4:127?50. 21. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009, 23:1327?337. 22. Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y: MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 2013, 12:30. 23. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006, 130:2113?129. 24. Yang H, Kong W, He L, Zhao JJ, O’Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008, 68:425?33. 25. Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM: MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res 2011, 42:281?90. 26. Liang Z, Li Y, Huang K, Wagar N, Shim H: Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN. Pharm Res 2011, 28:3091?100. 27. Ma F, Zhang J, Zhong L, Wang L, Liu Y, Wang Y, Peng L, Guo B: Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling. Gene 2014, 535:191?97. 28. Zhu J, Chen L, Zou L, Yang P, Wu R, Mao Y, Zhou H, Li R, Wang K, Wang W, Hua D, Zhang X: MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Hum Immunol 2014, 75:348?53. 29. Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W, Zhou Y, Ou Y, Lin X, Lin Y, Xu D, Yan G: Targeting oncogenic Baicalein 6-methyl ether price miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer 2011, 10:59. 30. Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q, Lan K: A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Res 2011, 21:793?06. 31. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26778282 Delta C(T)) Method. Methods 2001, 25:402?08.doi:10.1186/2045-3701-4-62 Cite this article as: Zhou et al.: MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN). Cell Bioscience 2014 4:62.Submit your next manuscript to BioMed Central and take full advantage of:?Convenient onl.
